<?xml version="1.0" encoding="UTF-8"?>
<ref id="B38-ijerph-17-04951">
 <label>38.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Falade-Nwulia</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Sulkowski</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>Merkow</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Latkin</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Mehta</surname>
    <given-names>S.H.</given-names>
   </name>
  </person-group>
  <article-title>Understanding and addressing hepatitis C reinfection in the oral direct-acting antiviral era</article-title>
  <source>J. Viral Hepat.</source>
  <year>2018</year>
  <volume>25</volume>
  <fpage>220</fpage>
  <lpage>227</lpage>
  <pub-id pub-id-type="doi">10.1111/jvh.12859</pub-id>
  <pub-id pub-id-type="pmid">29316030</pub-id>
 </element-citation>
</ref>
